A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma

Publisher： Karger

E-ISSN： 1421-9832|208|1|49-54

ISSN： 1018-8665

Source： Dermatology, Vol.208, Iss.1, 2004-02, pp. : 49-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alopecia areata Induced by Adjuvant Treatment with Alpha-Interferon in Malignant Melanoma?

By  

Dermatology, Vol. 209, Iss. 3, 2004-09 ,pp. : 249-250

Karger

Access to resources Recommend Favorite

Hypertriglyceridaemia during Low-Dose Interferon Alpha-2b Treatment in a Patient with Kaposi’s Sarcoma

By  

Dermatology, Vol. 202, Iss. 4, 2001-07 ,pp. : 345-345

Karger

Access to resources Recommend Favorite

Serum Levels of Glycoprotein Dickkopf-1 in Patients with Cutaneous Malignant Melanoma: A Prospective Pilot Study

By  

Dermatology, Vol. 222, Iss. 2, 2011-03 ,pp. : 171-175

Karger

Access to resources Recommend Favorite

Classic Kaposi’s Sarcoma: Low-Dose Interferon Alfa Treatment

By  

Dermatology, Vol. 197, Iss. 1, 1998-07 ,pp. : 37-42

Karger

Access to resources Recommend Favorite

Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant Melanoma

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 135-138

Karger

Access to resources Recommend Favorite